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levels of key regulators of mitochondrial biogenesis  in  insulin‐sensitive GHRKO mice. The aim of the present study  is to
assess, using real‐time PCR, the gene expression of key regulators of mitochondrial biogenesis (Pgc1α, Ampk, Sirt1, Nrf2
and Mfn2) and a marker of mitochondrial activity (CoxIV)  in brains, kidneys and  livers of male and female LiGHRKO and
wild‐type  (WT) mice. There were significant differences between males and  females.  In  the brain, expression of Pgc1α,
Ampk, Sirt1, Nrf2 and Mfn2 was lower in pooled females compared to pooled males. In the kidneys, expression of Ampk
and Sirt1 was also  lower  in  female mice.  In the  liver, no differences between males and  females were observed. Sexual
dimorphism may play an important role in regulating the biogenesis of mitochondria.  
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INTRODUCTION 
 
The biogenesis of mitochondria is a process by which 
new mitochondria are formed and is critical for cell 
viability [1]. Mitochondria are complex eukaryotic 
organelles that play a crucial role in energy homeostasis 
and metabolism. Disruption of mitochondrial biogenesis 
may lead, via impaired oxidative stress resistance and 
maintenance of energy production, to the development 
of numerous degenerative and metabolic diseases [2, 3]. 
On the contrary, increased level of mitochondrial 
biogenesis may prevent aging [4].  
 
There are numerous key regulators of mitochondrial 
biogenesis, including peroxisome proliferator-activated 
receptor gamma (PPARγ) co-activator 1 alpha (PGC1α), 
AMP-activated protein kinase (AMPK), sirtuin 1 
(SIRT1), nuclear respiratory factor 2 (NRF2) and 
mitofusin 2 (MFN2). Additionally, cytochrome c oxidase 
(COX) is one of the mitochondrial activity markers.  
 
PGC1α is the master regulator of mitochondrial 
biogenesis. This transcriptional coactivator coordinates 
the actions of several transcription factors and thereby 
controls mitochondrial biogenesis (reviewed by [3]). 
AMPK plays an important role as a cellular energy 
sensor and is activated by an increase in intracellular 
adenosine monophosphate (AMP)/adenosine triphospha-
te (ATP) ratio [5]. Sirtuin 1, sometimes referred to as a 
nutrient deprivation sensor, belongs to the sirtuin 
(NAD+–dependent deacetylases) family and stimulates 
mitochondrial biogenesis via PGC1α deacetylation [3]. 
NRF2 is a nuclear-encoded transcription factor that binds 
and activates various mitochondrial genes required for 
electron transport and oxidative phosphorylation 
[6]. MFN2 plays an essential role in mitochondrial fusion 
and maintenance of the mitochondrial network 
architecture [7, 8], which is essential for mitochondrial 
activity and biogenesis.  
 
Long-lived mice with targeted global disruption of the 
growth hormone (GH) receptor (GHR) gene (Ghr gene) 
(GHRKO; GHR knockout; Laron dwarfs; Ghr-/-) [9] are 
dwarf, obese and insulin sensitive [10]. We have 
previously shown increased expression of key regulators 
of mitochondrial biogenesis, including PGC1α, AMPK, 
SIRT1, eNOS and MFN2 in the kidneys and heart of 
GHRKO mice [11-13]. Moreover, GHRKO mice have 
decreased levels of pro-apoptotic factors [13-16] and 
decreased thyroid follicle size [17] with mild thyroid 
hypofunction. Interestingly, preservation of cognitive 
function in aging GHRKO mice was also observed [10]. 
Results obtained in these and in GH-deficient mice 
suggest an essential role of GH-induced intracellular 
signaling in lifespan regulation [18].  
Insulin-like growth factor 1 (IGF1) mediates many of 
GH’s physiological effects. IGF1 is primarily produced 
in the liver and acts systemically, although other tissues 
also may produce IGF1 where it may act locally (e.g., 
[19]). Therefore, suppression of GH signaling 
selectively in different tissues emerges as a very 
promising experimental approach to better understand 
the mechanisms involved in regulating the effects of the 
GH/IGF1 axis, and presumably in lifespan extension. 
Thus, mice with tissue-specific ablation of the Ghr gene 
recently have been generated [20-25], including mice 
with tissue-specific deletion of GHR (and disruption of 
GH signaling) in the liver (LiGHRKO). LiGHRKO 
mice have decreased body fat, severely reduced levels 
of circulating IGF1 and concurrently higher GH plasma 
levels [20, 25]. It is of particular interest that LiGHRKO 
mice show an absence of improved insulin sensitivity 
and severe hepatic steatosis [20, 25], which is in 
contrast to mice with global deletion of GHR. Both 
sexes of LiGHRKOs are characterized by elevated 
fasting blood glucose, while fasting insulin is higher 
only in males. Moreover, males have normal glucose 
tolerance and mild insulin resistance, while females are 
glucose intolerant and insulin resistant [25].  
 
A significant alterations in the weights of different organs 
(e.g., brain, kidneys and liver) between control and 
LiGHRKO mice were previously described [20, 25], 
suggesting potential differences in apoptosis as well as in 
mitochondrial function regulation, because mitochondria 
are known to play an important role in regulation of the 
process of apoptosis. Importantly, our recent studies 
demonstrated a sex-dependent expression of apoptosis-
related genes in the brain and kidneys of LiGHRKO mice 
without any significant main effects of sex in the liver 
[26]. Additionally, analysis of expression of the 
examined genes in the brains is related to the reported 
preservation of cognitive function in aging GHRKO mice 
[10]. For all these reasons, we decided to assess the effect 
of liver-specific Ghr gene disruption on gene expression 
of key regulators of mitochondrial biogenesis (Pgc1α, 
Ampk, Sirt1, Nrf2, Mfn2) and a marker of mitochondrial 
activity (CoxIV) in brains, kidneys and livers of males 
and females 22-month old LiGHRKO mice compared to 
males and females wild-type animals.  
 
We decided to use old mice for the following reasons. 
First of all, in our paper published recently [26], we 
have reported the sex dependence of the expression of 
apoptosis-related genes in 22-month old LiGHRKO 
mice. On the contrary, we did not find any differences 
in apoptotic factors gene expression in younger 9-
month-old mice (unpublished data).Thus, knowing the 
above-mentioned important role of mitochondria in the 
apoptosis regulation, we decided to analyze the gene 
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expression of the mitochondrial biogenesis-related 




Gene expression of key regulators of mitochondrial 
biogenesis in the brain 
 
In the brain, gene expression of Pgc1α, Ampk, Sirt1, Nrf2 
and Mfn2 was lower in pooled females than in pooled 












































respectively) (Figures 1A-E), demonstrating a significant 
sex effect. CoxIV showed a tendency for lower gene 
expression in female brains (p=0.055) (Figure 1F). 
Moreover, Ampk and Nrf2 expression was lower in brains 
of WT-females compared to WT-males (p=0.007 and 
p=0.024 respectively, with genotype*sex interactions 
reaching borderline statistical significance – p=0.054 and 
p=0.053, respectively) (Figures 1B and 1D). There was a 
weak and not statistically significant tendency for expres-
sion levels of all examined genes to be greater in female 







































































































Gene expression of key regulators of mitochondrial 
biogenesis in the kidneys 
 
In the kidneys, a decrease in gene expression of two 



















































Sirt1) in female compared to male mice was detected 
(a significant sex effect; p=0.041, p=0.003, 
respectively) (Figures 2B-C). Moreover, renal Sirt1 
gene expression was lower in WT-females than in 
WT-males (p=0.003) (Figure 2C). On the contrary, 
Figure 2. Renal gene expression of key regulators of mitochondrial biogenesis. Kidney mRNA expression of
Pgc1α (A), Ampk (B), Sirt1 (C), Nrf2 (D) and CoxIV (E) in male and female of wild‐type (WT) and liver‐specific growth
hormone  receptor knockout  (LiGHRKO) mice. Each group  consists of 7 animals. The data  from  real‐time PCR were
normalized by the housekeeping gene β2‐microglobulin (B2M) and shown as a relative expression. Values are means
±  SEM. a, b –  values  that do not  share  the  same  letter  in  the  superscript are  statistically  significant  (p<0.05). * –
p<0.05 vs. male mice (the significance for sex). There are the following significant p values: Ampk: 0.041, Sirt1: 0.003.
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there were no differences in the expression of Pgc1α, 
Nrf2 and CoxIV between male and female kidneys 
(p=0.366, p=0.315, p=0.242) (Figures 2A, 2D and 



















































there appeared to be a weak tendency for increased 
gene expression levels of the examined factors in 
female LiGHRKO mice as compared with WT-
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Gene expression of key regulators of mitochondrial 
biogenesis in the liver 
 
Intriguingly, in the liver, neither sex nor genotype 
significantly affected mRNA levels of the examined 
factors (Pgc1α, Ampk, Sirt1, Nrf2, Mfn2 and CoxIV; for 
sex – p=0.448, p=0.383, p=0.790, p=0.979, p=0.739, 
p=0.283, respectively and for genotype – p=0.335, 
p=0.677, p=0.921, p=0.371, p=0.215, p=0.938, 




Previous studies have shown increased levels of key 
regulators of mitochondrial biogenesis in mice with 
global GHR knockout [11, 12]. This increase was 
interpreted as a potentially beneficial characteristic of 
long-lived mice with global GHR deletion [13]. 
Therefore, one could envision that similar changes 
would be detected in the liver of mice with the same 
genetic intervention limited to the hepatic tissue 
(LiGHRKO). Surprisingly, deletion of the GHR only in 
the liver did not lead to any differences in gene 
expression of key regulators of mitochondrial 
biogenesis in this organ compared to wild-type mice. 
Thus, a main significant genotype effect has not been 
found. In two organs in which Ghr gene was not 
deleted, namely in brains and kidneys, there were also 
no significant effects of the genotype. These results may 
appear counterintuitive in the context of findings in 
global GHRKO mice, although it is known that 
LiGHRKO mice, in contrast to GHRKO animals, do not 
share the same phenotype in many aspects [20, 25], and 
have no change in lifespan (do not live longer) [27]. 
Furthermore, one should emphasize that our recent 
studies on the expression of apoptosis-related genes in 
LiGHRKO mice have also revealed an absence of 
genotype effect [26]. Apparently, effects of global GHR 
deletion differ from the effects of liver-specific GHR 
knockout. The observed differences strongly emphasize 
the necessity of further studies on the GH signaling 
regulation to elucidate which mechanisms involved in 
this process may play the most crucial role and why the 
disruption of the GHR in one tissue or organ may have 
completely opposite effects compared to global GHR 
deletion. 
 
Besides global GHRKO mice, the levels of key 
regulators of mitochondrial biogenesis have not yet 
been assessed in other long-lived mouse strains. 
However, there are studies on mitochondrial content 
and biogenesis in human subjects from the Leiden 
Longevity Study [28]. The authors have shown that the 
offspring of nonagenarians had lower mitochondrial 
DNA (mtDNA) content compared to age-matched 
controls, whereas nonagenarian parents had the lowest 
content of mtDNA [28].Thus, mtDNA has been shown 
to be negatively associated with familial longevity. The 
content of mtDNA may be considered a marker for the 
cellular amount of mitochondria and reflects the balance 
between mitochondrial biogenesis and removal of 
damaged mitochondria. Results of the study performed 
by Passtoors et al. [29] have demonstrated that familial 
longevity is also associated with reduced expression of 
genes involved in the mTOR pathway. It is known that 
this signaling pathway positively regulates genes 
involved in mitochondrial biogenesis, e.g., PGC1α [3]. 
Therefore, one could hypothesize that unaltered levels 
of key regulators of mitochondrial biogenesis in 
LiGHRKO mice, as seen in the present study, do not 
need to be considered a detrimental feature of these 
mutant mice. Observations by Malik and Czajka [30] 
showing opposite (decreased or increased) alterations in 
mtDNA content in numerous diseases, including those 
related to age (e.g., cancer or diabetes) also may support 
this hypothesis. Clearly, further work is required to fully 
elucidate the role of mitochondrial biogenesis regulation 
in the lifespan extension. 
 
As noted above, direction of changes in levels of key 
regulators of mitochondrial biogenesis in LiGHRKO 
mice differs from those previously demonstrated in 
GHRKO mutants. Moreover, observations in mice with 
tissue-specific deletion of the GHR (not only limited to 
the liver) point to different characteristics of these 
mutants compared to global GHRKO animals. For 
example, there is a lack of glucose homeostasis 
improvement in fat-specific GHRKO (FaGHRKO) mice 
[24]. Moreover, in contrast to global GHRKOs, mice 
with GHR deletion in muscles (MuGHRKO) are 
characterized by insulin resistance and glucose 
intolerance [21]. GHR disruption in pancreatic beta-
cells can lead to impaired insulin secretion [22]. 
Therefore, one could hypothesize that global GHR 
disruption with its numerous beneficial effects, but not 
tissue-specific knockout of Ghr gene, may play a 
crucial role in lifespan extension and resistance to the 
development of cancer and diabetes seen in GHRKO 
dwarfs [18].  
 
In the present study, a clear difference between sexes (a 
main significant sex effect) was demonstrated. Namely, 
our findings have shown that gene expression of key 
regulators of mitochondrial biogenesis was lower in 
females compared to male mice. Importantly, the results 
of recently published studies seem to support a 
hypothesis suggesting a potential role of sexual 
dimorphism in the regulation of biogenesis of 
mitochondria and may confirm the decreased intensity 
of this important process in females compared to males. 
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Sex-dependence of mitochondrial biogenesis was 
observed by Drake et al. [31] in their studies on proteins 
involved in mTOR signaling pathway. Furthermore, 
Straface et al. [32] hypothesize that differences between 
sexes may result from differences at the cellular level. 
Differences between males and females also have been 
reported by Sharma et al. [33], who demonstrated the 
lower gene expression of Pgc1α  in female cerebellar 
granule neurons (CGNs) than in male mice, resembling 
our findings in the brain. In contrast, gene expression of 
Pgc1α did not change in the other organs examined in the 
present study, namely in the kidneys and liver. These 
findings seem to be quite difficult to explain. However, 
van Leeuwen et al. [28] reported lack of association 
between PGC1α gene expression and mtDNA content. 
Moreover, similarly to our current results showing a 
decrease of Nrf2 and Mfn2 mRNA level, gene 
expressions of related factors – Nrf1 and Mfn1 in CGNs – 
were also decreased in females compared to males, 
although Mfn2 mRNA remained unchanged [33]. In 
Wistar rats, mtDNA content was lower in female brown 
adipose tissue than in the same tissue of males [34] and 
had a tendency to be decreased in female liver, although 
without statistically significant difference [35]. 
 
Intriguingly, in other studies, opposite results, i.e., 
increased level of mitochondrial biogenesis or function 
in the female sex, was detected. For example, in the 
Leiden Longevity Study, women had a higher mtDNA 
content than men [28]. Increased biogenesis of 
mitochondria may result from female sex hormones 
administration. Capllonch-Amer et al. [36] reported that 
17β-estradiol (E2) up-regulated the markers of 
mitochondrial biogenesis, dynamics and function in the 
skeletal muscles in rats. E2 also induced stimulation 
of mitochondrial biogenesis in white adipocytes in vitro 
[37]. Moreover, there is a wealth of evidence that 
demonstrates 17β-E2 increases lipid oxidation or 
improves metabolic parameters (reviewed by [38]). 
Therefore, one could hypothesize that females may be 
more efficient in substrate utilization even though  they 
have reduced mitochondrial biogenesis. Females may 
have more functional reserve so a diminishment of 
mitochondrial biogenesis or activity may not translate 
into metabolic perturbations. 
 
One should emphasize that there are clear sex 
differences in various characteristics of mice with local 
disruption of the GHR or with global GHR knockout. 
For example, increased local Igf1 gene expression in 
subcutaneous and retroperitoneal white adipose tissue 
and decreased levels of circulating insulin-like growth 
factor-binding protein-5 (IGFBP-5) and IGFBP-7 in 
female LiGHRKO mice compared to controls have been 
reported [25]. Moreover, List et al. [24] report that 
alterations in serum leptin and circulating interleukin 6 
levels as well as increased total lean body mass are 
present in female but not in male FaGHRKO mice. In 
GHRKO dwarfs, significant sex differences in the 
percent fat mass and in absolute lean mass have been 
reported [39]. These differences between male and 
female mice may be related to sex differences in GH 
secretion pattern and pituitary GH network responses 
[40]. Plasma GH pattern in males is characterized by 
high GH pulses occurring with a specific periodicity; in 
females, GH secretion is less variable with smaller GH 
pulses and higher interpulse levels [41].  
 
In summary, the role of GH signaling in the regulation 
of mitochondrial biogenesis appears to be much more 
complicated than once thought. Local deletion of the 
GHR in the liver may serve as a very useful 
experimental animal model for analyzing the role of 
tissue-specific disruption of GH signaling in the control 
of processes observed in living organisms. Importantly, 
sexual dimorphism may play a relevant role in the 
regulation of mitochondrial biogenesis under conditions 
of reduced GH signaling. Further studies are required to 
elucidate the relationships between GH-induced 
signaling, sex and mitochondria.  
 
MATERIALS AND METHODS 
 
Animals. LiGHRKO mice were generated at Ohio 
University as previously described [25]. Briefly, mice 
carrying the GHR “floxed” allele were crossed with 
B6.Cg-Tg(alb-cre)21Mgn/J transgenic mice purchased 
from Jackson Laboratories (Bar Harbor, ME USA) [24, 
25]. Brains, kidneys and livers from approximately 22-
month-old male and female wild-type (WT) and liver-
specific GHRKO (LiGHRKO) mice were provided 
from Mayo Clinic, Rochester, MN. The animals 
comprised four (4) experimental groups: wild-type 
males (WT-male), liver-specific GHR knockout males 
(LiGHRKO-male), wild-type females (WT-female) and 
liver-specific GHR knockout females (LiGHRKO-
female), each group consisting of 7 animals.  
 
RNA extraction and complementary DNA (cDNA) 
transcription. RNA was extracted from the homogenates 
of the examined tissues using a miRNeasy Mini Kit 
(Qiagen, USA) in accordance with the manufacturer’s 
instruction. RNA quantity and quality were analyzed 
using a NanoDrop 1000 Spectrophotometer (Thermo 
Scientific, USA). Reverse transcription was performed, 
and complementary DNA was synthesized using an 
iScript cDNA Synthesis Kit (Bio-Rad Laboratories, 
Hercules, CA, USA) according to the manufacturer’s 
instruction. 
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Real-time polymerase chain reaction (RT-PCR). Real-
time polymerase chain reaction (RT-PCR) was carried 
out using the StepOne™ Real-Time PCR System 
instrument (Life Technologies, USA) with iQ SYBR 
Green Supermix (Bio-Rad Laboratories, Hercules, CA, 
USA). The three steps of the PCR included: 
denaturation at 94°C for 2 minutes, annealing at 62°C 
for 30 seconds with fluorescence reading, and 
extension at 72°C for 30 seconds. In addition, a 
melting curve was done for each reaction to evaluate 
the potential of nonspecific products. β2-microglobulin 
(B2M), which was previously validated in our 
laboratory as the most appropriate gene for 
normalizing the data [12, 13, 42], was used as a 
housekeeping gene. Gene expression was assessed by 
measuring steady state levels of mRNA. Relative 
expression from RT-PCR was calculated using the 
equation 2A-B/2C-D (where A = Cycle Threshold [Ct] 
number for the gene of interest in the first control 
sample; B = Ct number for the gene of interest in the 
analyzed sample; C = Ct number for the housekeeping 
gene in the first control sample; D = Ct number for 
housekeeping gene in the analyzed sample). The first 
control was expressed as 1.00 by this equation, and all 
other samples were calculated in relation to this value. 
Then, the results in the control group (WT-males) 
were averaged. All other outputs were divided by the 
mean value of the relative expression in the control 


























genes of interest compared to the control group. For 
RT-PCR, the primers used are listed in Table 1. 
 
Statistical analysis. The data are expressed as mean ± 
SEM. To evaluate the main effects of the genotype and 
sex, we used two-way analysis of variance (ANOVA). 
For analyzing differences between group means, we 
used a Bonferroni post-hoc test. A value of p<0.05 was 
considered significant. All statistical calculations were 
conducted using SPSS version 17.0 (SPSS, Chicago, IL) 
with α=0.05. All graphs were created using Prism 4.02 
(GraphPad Software, San Diego, CA). 
 
To statistically analyze differences between males and 
females (a potential significant gender effect) we 
pooled all males (WT-male and LiGHRKO-male mice) 
and all females (WT-female and LiGHRKO-female 
mice) (see the Results section). Such statistical 
analysis may allow detect some potentially significant 
differences, which couldn’t been found when analysis 
between particular experimental groups was only 
performed. We would like also to emphasize that the 
employed method (pooling samples from male and 
female mice) is fully justified and statistically correct 
because the groups that were being combined (pooled) 
[i.e., WT-males and LiGHRKO-males (pooled into 
male group) vs. WT-females and LiGHRKO-females 
(pooled into female group)] were not significantly 


























Gene GenBank accession no. Forward (5’-3’) Reverse (5’-3’) 
β2-microglobulin NM_009735 aagtatactcacgccaccca aagaccagtccttgctgaag 
Pgc1α BC066868 tacgcaggtcgaacgaaact acttgctcttggtggaagca 
Ampk AF036535 cacttgtctgcatctctcca cttgaggaacttgaggatcc 
Sirt1 AY377984 gtaatgtgaggagtcagcac ttggacattaccacgtctgc 
Nrf2 U20532 tcagtgactcggaaatggag ttcacgcataggagcactgt 
Mfn2 NM_133201 ccacaaagtgagtgaacgtc atccaccagaaagctggtgc 
CoxIV NM_009941 acagcccttggcttgatgta tggcctgaaagcttccacta 
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